zidovudine has been researched along with Premature Birth in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (75.00) | 24.3611 |
2020's | 4 (25.00) | 2.80 |
Authors | Studies |
---|---|
Brandon, Z; Hemelaar, J; Johnson, B; Kirtley, S; Kumarendran, M; Murray, C; Portwood, C; Sexton, H | 1 |
Brummel, SS; Chamanga, R; Chi, BH; Dadabhai, S; DeMarrais, P; Fowler, MG; Owor, M; Price, JT; Sebikari, D; Stringer, J; Taha, T | 1 |
Aldrovandi, GM; Brummel, SS; Chipato, T; Currier, JS; Flynn, PM; Fowler, MG; Gadama, LA; Koos, BJ; Li, F; Mcintyre, JA; Murphy, A; Nakabiito, C; Saidi, F; Tobin, NH | 1 |
Chi, BH; Fairlie, L; Farhad, M; Fenton, T; Fowler, MG; Moodley, D; Naik, S; Nakabiito, C; Stringer, JSA; Venkatesh, KK | 1 |
Cheng, CY; Cheng, SH; Hu, YC; Hung, TC; Lee, CY; Lin, MH; Lu, LC | 1 |
Moodley, J; Sebitloane, HM | 1 |
Barr, E; Chadwick, EG; Currier, JS; Hernandez-Diaz, S; Hoffman, RM; Huo, Y; Patel, K; Rough, K; Seage, GR; Shapiro, DE; Williams, PL | 1 |
Darak, S; Darak, T; Hutter, I; Janssen, F; Kulkarni, S; Kulkarni, V; Parchure, R | 1 |
Blanche, S; Warszawski, J | 1 |
Douglas, M; Short, CE; Smith, JH; Taylor, GP | 1 |
Hemelaar, J; Montgomery-Taylor, S | 1 |
Albano, J; Gee, C; Koram, N; Tilson, H; Vannappagari, V | 1 |
Boer, K; England, K; Godfried, MH; Thorne, C | 1 |
Cortina-Borja, M; Newell, ML; Tookey, PA; Townsend, CL | 1 |
Ardonk, W; Borkird, T; Hinjiranandana, T; Hongsiriwon, S; Jourdain, G; Kanjanavanit, S; Khamduang, W; Krittigamas, P; Lallemant, M; Layangool, P; McIntosh, K; Nanta, S; Ngo-Giang-Huong, N; Pagdi, K; Sirinontakan, S; Sirirungsi, W; Somsamai, R | 1 |
Blanche, S; Dollfus, C; Ekoukou, D; Faye, A; Mandelbrot, L; Rouzioux, C; Sibiude, J; Teglas, JP; Tubiana, R; Warszawski, J | 1 |
2 review(s) available for zidovudine and Premature Birth
Article | Year |
---|---|
Adverse perinatal outcomes associated with HAART and monotherapy.
Topics: Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Zidovudine | 2022 |
[Tolerance of antiretroviral drugs during pregnancy].
Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mutagens; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Zidovudine | 2013 |
1 trial(s) available for zidovudine and Premature Birth
Article | Year |
---|---|
Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Topics: Adult; Anti-HIV Agents; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Logistic Models; Lopinavir; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Ultrasonography, Prenatal; Young Adult; Zidovudine | 2019 |
13 other study(ies) available for zidovudine and Premature Birth
Article | Year |
---|---|
Progesterone and prolactin levels in pregnant women living with HIV who delivered preterm and low birthweight infants: A nested case-control study.
Topics: Anti-Retroviral Agents; Birth Weight; Case-Control Studies; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Premature Birth; Progesterone; Prolactin; Zidovudine | 2023 |
Metabolomic profiling of preterm birth in pregnant women living with HIV.
Topics: Anti-HIV Agents; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Metabolomics; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Premature Birth; Protease Inhibitors; Zidovudine | 2023 |
Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Female; Fetal Development; HIV Infections; Humans; Infant, Small for Gestational Age; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Taiwan; Zidovudine | 2020 |
Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Prenatal Care; Retrospective Studies; South Africa; Urinary Tract Infections; Zidovudine | 2017 |
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Disease Transmission, Infectious; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Risk; Ritonavir; Tenofovir; Zidovudine | 2018 |
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Gestational Age; HIV Infections; Humans; India; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Premature Birth; Program Evaluation; Prospective Studies; Socioeconomic Factors; Viral Load; Young Adult; Zidovudine | 2013 |
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Viral Load; Zidovudine | 2014 |
Management and outcomes of pregnancies among women with HIV in Oxford, UK, in 2008-2012.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cesarean Section; Female; Gestational Age; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Risk Factors; Stillbirth; United Kingdom; Viral Load; Zidovudine | 2015 |
Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Infant, Low Birth Weight; Live Birth; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Exposure Delayed Effects; Prevalence; Registries; Risk Factors; Stillbirth; Young Adult; Zidovudine | 2016 |
Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cesarean Section; Delivery, Obstetric; Epidemiologic Methods; Europe; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Prenatal Care; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Viral Load; Young Adult; Zidovudine | 2010 |
Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Ireland; Monte Carlo Method; Population Surveillance; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Reverse Transcriptase Inhibitors; Risk Assessment; United Kingdom; Zidovudine | 2010 |
The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Retrospective Studies; Viral Load; Young Adult; Zidovudine | 2011 |
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Topics: Adult; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Female; France; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Zidovudine | 2012 |